NCT06784167View on ClinicalTrials.gov

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

RecruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

January 11, 2027

Study Completion Date

April 12, 2027

Conditions
Chronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular LymphomaMantle Cell LymphomaMultiple MyelomaPrimary Mediastinal Large B-Cell LymphomaSmall Lymphocytic Lymphoma
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

97239

RECRUITING

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER